Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director Dealing

26th Apr 2013 07:00

RNS Number : 2913D
Advanced Oncotherapy PLC
26 April 2013
 

26 April 2013

 

ADVANCED ONCOTHERAPY Plc

("Advanced Oncotherapy" or "the Company")

 

Director Dealing

 

Advanced Oncotherapy (AIM: AVO) announces that on 25 April 2013, Michael Sinclair, Chief Executive Officer, purchased 8,250,000 ordinary shares of 1 pence each in the share capital of the Company ("Ordinary Shares") at an average price of 1.655 pence per share.

 

Following this purchase, Michael Sinclair now holds 69,355,121 Ordinary Shares, representing approximately 26.7 per cent. of the issued share capital of Advanced Oncotherapy.

 

For further information, please visit www.advancedoncotherapy.comor contact:

 

Michael Sinclair,

Chief Executive

Sandy Jamieson

Jon Levinson

Simon Hudson

Advanced

Oncotherapy Plc

Libertas Capital

Corporate Finance Ltd

Peterhouse

Corporate Finance

Tavistock Communications

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR & IR)

+44 20 3617 8739

+44 20 7569 9650

+44 20 7469 0930

+44 20 7920 3150

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBIGDSDDDBGXU

Related Shares:

AVO.L
FTSE 100 Latest
Value8,809.74
Change53.53